Biotime, an innovative healthcare manufacturer, is pleased to announce its remarkable presence and achievements at three prominent international medical exhibitions.

The company showcased its cutting-edge products at the South Africa International Medical Equipment Exhibition - Africa Health (see figure 1.), the Hospital Expo in Indonesia (see figure 2.) and Health Asia in Pakistan (see figure 3.). Through these events, Biotime engaged in fruitful discussions with global customers and partners, exploring new technologies and products in the ever-evolving healthcare industry.

Biotime's immunoassay fluorescence products stole the spotlight at the exhibitions, attracting significant attention from attendees. The products' user-friendly operation and exceptional accuracy in delivering results impressed scholars, experts, and distributors alike. Visitors had the invaluable opportunity to interact with Biotime's technical team, gaining profound insights into the technological features and application advantages of the company's immunoassay fluorescence platform.

(figure1. Africa Health 2023)

(figure 2.Hospital Expo 2023)

(figure 3.Health Asia 2023)

At present, Biotime's immunoassay fluorescence testing platform covers a wide range of series, including cardiovascular, inflammation, hormones, thyroid function, diabetes, and renal injury. The platform boasts an impressive turnaround time, with results available in as fast as 3 minutes. Additionally, it seamlessly integrates with various instruments, such as the single-channel BIOT-YG-I Immunoassay Fluorescence Analyzer, the six-channel FLI-600 Dry Fluorescence Immunoassay Analyzer, and the FLI-4000 Fully Automated Dry Fluorescence Immunoassay Analyzer. This versatility effectively caters to the diverse testing needs of different medical institutions.

We are elated with with the success and acclaim garnered at these international medical exhibitions. Our groundbreaking immunoassay fluorescence products have captured the industry's interest, and we take immense pride in our contribution to advancing healthcare technologies on a global scale. Our dedication to driving progress in the medical industry remains steadfast, as we continue to develop solutions that enhance patient care.